Scaling-up antiretroviral therapy in Malawi;Élargir l’accès aux traitements antirétroviraux au Malawi;Ampliación de la terapia antirretroviral en Malawi

Bulletin of the World Health Organization

Volumn 94, Issue 10, 2016, Pages 772-776

  Jahn, Andreas ^a   Harries, Anthony D ^b   Schouten, Erik J ^c   Libamba, Edwin ^d   Ford, Nathan ^e   Maher, Dermot ^e   Chimbwandira, Frank ^a  

^a MINISTRY OF HEALTH   (Malawi)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c Management Sciences for Health   (Malawi)

^d Baylor College of Medicine Abbott Fund Children's Clinical Center of Excellence   (Malawi)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ANTIRETROVIRUS AGENT;

DECENTRALIZATION; DISEASE TREATMENT; GUIDELINE; HEALTH CARE; HOSPITAL SECTOR; HUMAN IMMUNODEFICIENCY VIRUS; MONITORING SYSTEM; PUBLIC HEALTH; STATE ROLE;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL SUPERVISION; HEALTH CARE PLANNING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALAWI; MONITORING; PREGNANT WOMAN; PROVOCATION TEST; PUBLIC HEALTH; SCALE UP; STAFF TRAINING; SYSTEM ANALYSIS; DRUG EFFECTS; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PROGRAM DEVELOPMENT;

MALAWI;

HUMAN IMMUNODEFICIENCY VIRUS;

ANTI-RETROVIRAL AGENTS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HIV INFECTIONS; HIV-1; HUMANS; MALAWI; MALE; PROGRAM DEVELOPMENT; PUBLIC HEALTH;

EID: 84989321841     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.15.166074     Document Type: Article

References (17)

1. World health statistics. Geneva: World Health Organization; 2014.
2. National estimates of HIV/AIDS in Malawi. Lilongwe: National AIDS Commission; 2005.
3. Harries AD, Makombe SD, Schouten EJ, Jahn A, Libamba E, Kamoto K, et al. How operational research influenced the scale up of antiretroviral therapy in Malawi. Health Care Manage Sci. 2012 Sep;15(3):197-205. doi: http://dx.doi.org/10.1007/s10729-011-9187-2 PMID: 22113539
4. st ed. Lilongwe: Ministry of Health and Population, Government of Malawi; 2003.
5. Douglas GP, Gadabu OJ, Joukes S, Mumba S, McKay MV, Ben-Smith A, et al. Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med. 2010 08 10;7(8):e1000319. doi: http://dx.doi.org/10.1371/journal. pmed.1000319 PMID: 20711476
6. Libamba E, Makombe S, Mhango E, de Ascurra Teck O, Limbambala E, Schouten EJ, et al. Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bull World Health Organ. 2006 Apr;84(4):320-6. PMID: 16628306
7. Harries AD, Schouten EJ, Makombe SD, Libamba E, Neufville HN, Some E, et al. Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bull World Health Organ. 2007 Feb;85(2):152-5. doi: http://dx.doi.org/10.2471/BLT.06.032060 PMID: 17308737
8. Integrated HIV program report, October-December 2015. Lilongwe: Ministry of Health, Government of Malawi; 2015. Available from: http://www.hiv.health.gov.mw/index.php/our-documents [cited 2016 April 6].
9. Clinical management of HIV in children and adults. Malawi integrated guidelines for providing HIV services in antenatal care, maternity care, under-5 clinics, family planning clinics, exposed infant/pre-ART clinics and ART clinics. Lilongwe: Ministry of Health, Government of Malawi; 2011.
10. Harries AD, Makombe SD, Libamba E, Schouten EJ. Why did the scale-up of HIV treatment work? A case example from Malawi. J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 2:S64-7. doi: http://dx.doi.org/10.1097/QAI.0b013e31821f6bab PMID: 21857298
11. Lowrance D, Makombe S, Harries A, Yu J, Aberle-Grasse J, Eiger O, et al. Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi. J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):56-61. PMID: 17972365
12. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach. 2010 version. Geneva: World Health Organization; 2010.
13. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet. 2011 Jul 16;378(9787):282-4. doi: http://dx.doi.org/10.1016/S0140-6736(10)62303-3 PMID: 21763940
14. Haas AD, Tenthani L, Msukwa MT, Tal K, Jahn A, Gadabu OJ, et al. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi’s option B+ programme: an observational cohort study. Lancet HIV. 2016 Apr;3(4):e175-82. doi: http://dx.doi.org/10.1016/S2352-3018(16)00008-4 PMID: 27036993
15. Harries AD, Zachariah R, van Oosterhout JJ, Reid SD, Hosseinipour MC, Arendt V, et al. Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis. 2010 Jan;10(1):60-5. doi: http://dx.doi. org/10.1016/S1473-3099(09)70321-4 PMID: 20129150
16. Glass RI. HIV/AIDS and noncommunicable disease comorbidities: emerging research priorities. J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S1. doi: http://dx.doi.org/10.1097/QAI.0000000000000266 PMID: 25117956
17. Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015.